Biotech / MedTech
NASDAQ-bound Singaporean biotech firm AUM Biosciences aims to be key player in global precision oncology space
In the interview ahead of the company’s de-SPAC, CEO also shared about the challenges and opportunities as the precision oncology space, the company's immediate plan following its listing. He also shared his views on the biotech landscape in Southeast Asia and gave several suggestions for for companies, governments, and investors for the biotech industry in…
Indonesia’s Etana secures financing from DEG, East Ventures and others
PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures.
EV, bioeconomy among industries poised for exponential growth, says investor & author Azeem Azhar
Azeem is one of the speakers at the DLD Conference held between January 12 and 14 in Munich, Germany.
Indonesia’s Widjaja Family Investment Office leads US’s Alio $18M funding round
Alio, Inc., a United States-based medical technology company reinventing the management of chronic disease, announced it has raised $18 million in the initial close of a Series C financing, bringing the total amount the company has raised to over $50 million. The financing was led by the Widjaja Family Investment Office with participation from the company’s…
Singapore’s AUM Biosciences plans to go public via SPAC merger
Singapore-based biotechnology company AUM Biosciences (AUM) plans to go public on Nasdaq via a special purpose acquisition company (SPAC) merger with Mountain Crest Acquisition Corp.
Singapore’s Nutrition Technologies closes $20M equity round led by PTT Ventures
Singapore-based agri-biotech company Nutrition Technologies has on Monday completed an equity venture round of $20 million led by PTT Ventures. The round was supported by Sumitomo Corporation, ING Sustainable Investments, Mandala Capital.
India’s Loopworm raises $3.4M seed round co-led by Omnivore and WaterBridge
India's insect biotech startup Loopworm announced Wednesday that it has raised a $3.4 million seed round co-led by Omnivore and WaterBridge Ventures. The round also saw participation from Titan Capital and leading angel investors including Nadir Godrej (Godrej Agrovet), Sanjiv Rangrass (ex-ITC), and Akshay Singhal (Log9 Materials).
Cordlife partners AMILI to launch gut microbiome banking service in Southeast Asia
Cordlife Group Limited (Cordlife), a Singapore Exchange mainboard listed consumer healthcare company, and AMILI Pte. Ltd. (AMILI), a Singapore-based microbiome firm, announced Tuesday a strategic partnership to provide the first-ever gut microbiome banking service in Singapore and the region.
Singapore’s AMILI raises $10.5M Series A round led by Vulcan Capital
AMILI, a Singapore-based precision gut microbiome company, said Wednesday it has raised$10.5 million in Series A funding to accelerate its business expansion in Southeast Asia and Greater Asia. The round was led by Vulcan Capital, the investment arm of the late Microsoft Corp co-founder Paul Allen that invests in category-leading technology, internet, and…
